Saroja Pharma Ind Key Ratios

NSE: SAROJA

₹36.00

₹0.00 (0.00%)

As on 20-Nov-2026 13:01IST

Market cap

info icon

₹14 Cr

Revenue (TTM)

info icon

₹70 Cr

P/E Ratio

info icon

9

P/B Ratio

info icon

0.8

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 30.53 11.79 13.85
EBIT -- -- 35.13 10.84 23.02
Net Profit -- -- 56.10 15.03 17.16
EPS -- -- 56.10 3.58 -41.02
Book Value -- -- 10.30 35.39 -9.79
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-26Mar-25Mar-24
EBIT-Margin info 5.405.035.154.986.06
Net Margin info 2.122.102.301.922.15
Return on equity info 8.5118.959.796.828.90
Return on Capital info 13.5219.2813.1012.5614.91
Return on Assets info 3.595.233.973.133.67
Debt to Equity (x) info ----0.830.600.39
ROCE

13.10

Higher than Peers by 12.25

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
13.10
12.56
14.91
22.10
33.73
Peer Median
0.85
9.15
9.86
10.38
--
ROE

9.79

Higher than Peers by 8.95

Profit after tax / Average Net worth * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
9.79
6.82
8.90
23.28
45.95
Peer Median
0.85
5.99
5.33
7.17
--
ROA

3.97

Higher than Peers by 3.21

Profit after tax / Average Total assets * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
3.97
3.13
3.67
5.76
9.61
Peer Median
0.76
3.67
4.83
5.33
--
EBIT Margin

5.15

Higher than Peers by 7.08

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
5.15
4.98
6.06
5.29
3.70
Peer Median
-1.93
1.57
-0.69
-7.53
--
Net Margin

2.30

Higher than Peers by 0.55

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
2.30
1.92
2.15
2.11
2.04
Peer Median
1.75
7.26
3.51
5.34
--
Cash Profit Margin

2.46

Higher than Peers by 2.46

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
2.46
2.14
2.39
2.25
2.13
Peer Median
0.00
0.00
0.00
0.00
--
Revenue Growth

30.53

Lower than Peers by 3.40

Year on year growth in net sales

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
30.53
32.11
-18.97
-9.78
51.75
Peer Median
33.93
59.03
23.78
185.48
--
EBIT Growth

35.13

Higher than Peers by 31.87

Year on year growth in operating profit (EBIT)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
35.13
8.52
-7.14
28.98
60.42
Peer Median
3.27
0.71
-39.89
5.86
--
Net Profit Growth

56.10

Higher than Peers by 17.40

Year on year growth in profit after tax

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
56.10
17.75
-17.19
-6.97
55.90
Peer Median
38.70
2.24
-1.56
-29.54
--
EPS Growth

56.10

Higher than Peers by 40.54

Year on year growth in earnings per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
56.10
17.75
-39.53
-6.98
-93.10
Peer Median
15.56
15.99
20.00
-25.00
--
Book Value Growth

10.30

--

Year on year growth in book value per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
10.30
7.06
187.84
26.34
330.17
Peer Median
--
--
--
--
--
Debt to Equity

0.83

Higher than Peers by 0.83

Total debt / Net worth

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
0.83
0.60
0.39
2.00
1.52
Peer Median
0.00
0.00
0.00
0.08
--
Short term debt to equity ratio

0.35

--

(Short term borrowings / Net worth)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
0.35
0.52
0.21
1.45
1.10
Peer Median
--
--
--
--
--
Current Ratio

1.09

Lower than Peers by 0.65

Current Assets / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
1.09
1.21
1.89
1.20
1.54
Peer Median
1.73
1.97
2.54
2.22
--
Quick Ratio

1.04

Lower than Peers by 0.62

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
1.04
1.21
1.85
0.91
1.49
Peer Median
1.66
2.38
3.33
2.05
--
Interest Coverage

2.50

Lower than Peers by 3.32

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
2.50
2.03
1.83
2.13
2.97
Peer Median
5.82
8.07
18.49
8.15
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

24.67

Higher than Peers by 2.14

Debtors outstanding / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
24.67
49.47
39.93
22.13
25.13
Peer Median
22.53
19.70
17.80
21.35
--
Asset Turnover

1.73

Higher than Peers by 0.88

Sales / Average Total Assets

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
1.73
1.63
1.70
2.72
4.69
Peer Median
0.84
1.87
0.60
0.25
--
Receivable days

114.19

--

Average Debtors / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
114.19
145.45
122.72
91.22
69.56
Peer Median
--
--
--
--
--
Inventory Days

2.49

--

Average Inventory / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
2.49
1.69
19.13
15.75
3.68
Peer Median
--
--
--
--
--
Payable days

64.92

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
64.92
74.63
61.58
45.99
35.58
Peer Median
--
--
--
--
--
Cash Conversion Cycle

51.77

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
51.77
72.50
80.28
60.98
37.66
Peer Median
--
--
--
--
--
Price / Earnings

6.97

Lower than Peers by 27.69

Current share price divided by earning per share in the last twelve months

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
6.97
14.68
16.07
--
--
Peer Median
34.66
25.87
30.13
23.66
--
Price / Book Value

0.65

Lower than Peers by 0.29

Current share price divided by book value per share in the latest financial year

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
0.65
0.97
0.96
--
--
Peer Median
0.94
1.84
1.22
0.81
--
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
--
--
--
--
--
Peer Median
0.64
--
0.43
0.69
--
EV/EBITDA

6.61

Higher than Peers by 15.91

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
6.61
8.17
7.10
4.43
2.51
Peer Median
-9.30
-24.50
-39.62
-10.36
--
Market Cap

11

Lower than Peers by 137

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Saroja Pharma Ind
11
15
14
--
--
Peer Median
148
160
199
362
--
loading...
loading...
loading...